Skip to search boxSkip to navigationSkip to main content

Predicting Mechanical Ventilation Using the EGRIS in Guillain–Barré Syndrome in a Latin American Country

  • Marco Malaga
    ,
  • Aaron Rodriguez-Calienes
    ,
  • Adrian Marquez-Nakamatsu
    ,
  • Katherine Recuay
    ,
  • Luis Merzthal
    ,
  • Diego Bustamante-Paytan
*Corresponding author for this work
  • Universidad de San Martin de Porres
    ,
  • docencia y atención especializada en epilepsia
    ,
  • Hospital Nacional Arzobispo Loayza
    ,
  • ,
  • Hospital Daniel Alcides Carrión
    ,
  • Universidad Científica del Sur
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 775-782 (8 pages)

Journal (Volume, Issue Number)

Neurocritical Care (Volume 35, Issue 3)

Publication milestones

  • Accepted/In press - 2021
  • Published - 12/2021

Publication status

Published - 12/2021

ISSN

1541-6933

Publication IDs

  • Scopus: 85106309486

Abstract

Background: Up to one fifth of patients with Guillain–Barré syndrome (GBS) require mechanical ventilation (MV). The Erasmus GBS Respiratory Insufficiency Score (EGRIS) is a clinical predictive model developed in Europe to predict MV requirements among patients with GBS. However, there are significant differences between the Latin American and European population, especially in the distribution of GBS subtypes. Therefore, determining if the EGRIS is able to predict MV in a Latin American population is of clinical significance. Methods: We retrospectively analyzed clinical and laboratory data of 177 patients with GBS in three Peruvian hospitals. We performed a multivariate logistic regression of the factors making up the EGRIS. Finally, we evaluated the EGRIS discrimination through a receiver operating characteristic curve and determined its calibration through a calibration curve and a Hosmer–Lemeshow test, a test used to determine the goodness of fit. Results: We found that 14.1% of our patients required MV. One predictive factor of a patient’s need for early MV was the number of days between the onset of motor symptoms and hospitalization. The Medical Research Council sum score did not alter the likelihood of early MV. Bulbar weakness increased the likelihood without showing statistical significance. In contrast, facial weakness was a protective factor of it. The EGRIS was significantly higher in patients who required early MV than in those who did not (P = 0.018). It showed an area under the curve (AUC) of 0.63, with an insignificant Hosmer–Lemeshow test result. Conclusions: Although the EGRIS was higher in patients who required early MV than in those who did not, it only showed a moderate discrimination capacity (AUC = 0.63). Facial weakness, an item of the EGRIS, was not found to be a predictive factor in our population. We suggest assessing whether these findings are due to subtype predominance and whether a modified version of the EGRIS could improve performance.

Funding Details

We thank Dr. Victor Velasquez, from Red de Eficacia Clínica y Sanitaria, for his review of the manuscript.
FundersFunding numbers
Red de Eficacia Clínica y Sanitaria
-